Skip to content

PEDI-REAVASC Resonance Imaging of Infants With Hypoxic Ischemic Encephalopathy After Hypothermia Treatment.

Quantitative Assessment of Cerebral Vascular Reactivity by Resting Functional Magnetic Resonance Imaging of Infants With Hypoxic Ischemic Encephalopathy After Hypothermia Treatment: Diagnostic and Prognostic Implications.

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06370624
Acronym
PEDI-REAVASC
Enrollment
30
Registered
2024-04-17
Start date
2023-01-17
Completion date
2025-10-01
Last updated
2025-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Encephalopathy, Hypoxic-Ischemic

Brief summary

This study is a prospective, observational, single-center study to assess the correlation between rs-fMRI measures and clinical measures of standard MRI, NIRS, EEG and clinical scores. The target population was neonates with HIE referred to MRI after hypothermia treatment, which was initiated within 6 hours of birth, continued for 72 hours and followed by a slow rewarming period of 6-12 hours. A one-year clinical and imaging follow-up is planned. As the aim of the present study is to assess the predictiveness of the outcome one year after the HIE event, no follow-up is planned.

Interventions

DIAGNOSTIC_TESTMRI-scan

IRM-scan at rest under neonatologist monitoring.

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

One group will be followed - with both the standard of care continuous EEG monitoring and near infrared spectroscopy (NIRS) & the MRI-scan performed at the same time.

Eligibility

Sex/Gender
ALL
Age
1 Hours to 14 Months
Healthy volunteers
No

Inclusion criteria

Newborns at 36 weeks gestation or more, with HIE treated with therapeutic hypothermia will be prospectively included.

Exclusion criteria

* Lack of parental consent * Congenital anomalies that make hypothermia treatment not indicated * Coagulopathy with active bleeding

Design outcomes

Primary

MeasureTime frameDescription
quantifying cerebrovascular reactivity (CVR) by resting-state functional MRI (r-fMRI) in infants with moderate to severe hypoxic-ischaemic encephalopathy (HIE)at birth, directly after hypothermia and at 1 year of baby's lifeCorrelation between RCV mapping EEG/MRI

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026